标题
Insulin Detemir
作者
关键词
-
出版物
DRUGS
Volume 72, Issue 17, Pages 2255-2287
出版商
Springer Nature
发表日期
2012-10-31
DOI
10.2165/11470200-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- INSULIN DETEMIR IN ROUTINE CLINICAL PRACTICE: A 26-WEEK FOLLOW-UP IN TYPE 1 DIABETIC PATIENTS FROM THE BELGIAN PREDICTIVE COHORT
- (2014) V. Preumont et al. ACTA CLINICA BELGICA
- Response to Comment on: Winkler et al. Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis. Diabetes 2012;61:513-523
- (2012) U. Kintscher DIABETES
- Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets
- (2012) J. H. DeVries et al. DIABETES CARE
- Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes
- (2012) E. R. Mathiesen et al. DIABETES CARE
- Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice
- (2012) K. Khunti et al. DIABETES OBESITY & METABOLISM
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Switching Patients with Type 2 Diabetes from Insulin Glargine to Insulin Detemir in Chinese Setting: A Health Economic Model Based on the PREDICTIVE Study
- (2012) Li Yang et al. VALUE IN HEALTH
- Insulin detemir for the treatment of obese patients with type 2 diabetes
- (2012) Priscilla Hollander Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects: A randomized cross-over study
- (2011) P. Lucidi et al. DIABETES CARE
- Insulin Detemir Reduces Weight Gain as a Result of Reduced Food Intake in Patients With Type 1 Diabetes
- (2011) S. Zachariah et al. DIABETES CARE
- Standards of Medical Care in Diabetes--2012
- (2011) DIABETES CARE
- A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations
- (2011) M. Evans et al. DIABETES OBESITY & METABOLISM
- Pharmacokinetics and Pharmacodynamics of Basal Insulins
- (2011) Francesca Porcellati et al. Diabetes Technology & Therapeutics
- Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands
- (2011) W. J. Valentine et al. DIABETIC MEDICINE
- Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients
- (2011) K. V. Hendriksen et al. DIABETOLOGIA
- Improved glycemic control with weight loss and a low risk of hypoglycemia with insulin detemir: insights from the Italian cohort of the PREDICTIVE study after 6-month observation in type 2 diabetic subjects
- (2011) Gabriele Perriello et al. EXPERT OPINION ON PHARMACOTHERAPY
- Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus
- (2011) Nandu Thalange et al. PEDIATRIC DIABETES
- Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years
- (2011) Haim Werner et al. Diabetology & Metabolic Syndrome
- Euglycemic Infusion of Insulin Detemir Compared With Human Insulin Appears to Increase Direct Current Brain Potential Response and Reduces Food Intake While Inducing Similar Systemic Effects
- (2010) M. Hallschmid et al. DIABETES
- A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs
- (2010) S. G. Swinnen et al. DIABETES CARE
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor
- (2010) A. R. Sørensen et al. DIABETES OBESITY & METABOLISM
- Co-administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction
- (2010) L. Morrow et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial
- (2010) P. Hollander et al. DIABETES OBESITY & METABOLISM
- Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
- (2010) A. R. Chacra et al. DIABETIC MEDICINE
- Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24-h euglycaemic clamp studies in healthy humans
- (2010) L. P. Sørensen et al. DIABETIC MEDICINE
- How pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes
- (2010) S. Arnolds et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Insulin detemir is not transported across the blood–brain barrier
- (2010) William A. Banks et al. PEPTIDES
- Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden
- (2010) William J. Valentine et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
- (2010) Jean-Pierre Le Floch Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial
- (2009) Jean-Louis Selam et al. ADVANCES IN THERAPY
- Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial
- (2009) Simon Heller et al. CLINICAL THERAPEUTICS
- Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study
- (2009) Jean-Louis Selam et al. CURRENT MEDICAL RESEARCH AND OPINION
- Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis
- (2009) Sandra L. Tunis et al. CURRENT MEDICAL RESEARCH AND OPINION
- Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study
- (2009) L. F. Meneghini et al. CURRENT MEDICAL RESEARCH AND OPINION
- Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE™ study in a cohort of French patients with type 1 or type 2 diabetes
- (2009) M. Marre et al. DIABETES & METABOLISM
- Insulin detemir causes increased symptom awareness during hypoglycaemia compared to human insulin
- (2009) O. Tschritter et al. DIABETES OBESITY & METABOLISM
- Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATETMstudy
- (2009) L. Blonde et al. DIABETES OBESITY & METABOLISM
- Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: Evidence from the PREDICTIVE™ study
- (2009) Leo Niskanen et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes
- (2009) Philip Raskin et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes
- (2009) L. Fogelfeld et al. DIABETIC MEDICINE
- Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes
- (2009) F. Smeeton et al. DIABETOLOGIA
- No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis
- (2009) A. Dejgaard et al. DIABETOLOGIA
- Short-Term Effects of the Long-Acting Insulin Analog Detemir and Human Insulin on Plasma Levels of Insulin-Like Growth Factor-I and Its Binding Proteins in Humans
- (2009) Francesca Porcellati et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
- (2009) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE™ observational study
- (2009) Selim Kurtoglu et al. PEDIATRIC DIABETES
- Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries
- (2009) Manuela Helena Gschwend et al. JOURNAL OF MEDICAL ECONOMICS
- Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes
- (2008) William J. Valentine et al. ADVANCES IN THERAPY
- Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus
- (2008) Udaya M Kabadi CLINICAL DRUG INVESTIGATION
- A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes
- (2008) Priscilla Hollander et al. CLINICAL THERAPEUTICS
- Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 Diabetes: Assessment of Detemir Administration in a Progressive Treat-To-Target Trial (ADAPT)
- (2008) J.-P. Le Floch et al. DIABETES CARE
- Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
- (2008) J. S. Skyler et al. DIABETES CARE
- Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study
- (2008) A. B. King DIABETES OBESITY & METABOLISM
- Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial
- (2008) A. Liebl et al. DIABETES OBESITY & METABOLISM
- Reduced Weight Gain with Insulin Detemir Compared to NPH Insulin Is Not Explained by a Reduction in Hypoglycemia
- (2008) Melanie J. Davies et al. Diabetes Technology & Therapeutics
- Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial
- (2008) P. C. Bartley et al. DIABETIC MEDICINE
- Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients-The PREDICTIVE™ BMI clinical trial1
- (2008) C. Fajardo Montañana et al. DIABETIC MEDICINE
- A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
- (2008) J. Rosenstock et al. DIABETOLOGIA
- Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study
- (2008) A. Dornhorst et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now